Vascular Surgery Research

In addition to their clinical training, the vascular surgery 5-2 residents are expected to participate in clinical research projects throughout their fellowship. Clinical research is supported by the Division with dedicated statistical support and research nurse coordinator. Fellows select research projects based on their individual interests and experience. Presentation of research occurs at regional and national meetings with submission of manuscripts to peer-reviewed journals.
Areas of current faculty research interest include:

  • Outcomes of peripheral vascular interventions Gender and outcomes of peripheral vascular interventions and infrainguinal bypass
  • Perioperative cardiac risk assessment for vascular surgery
  • Impact of postoperative glucose control on infrainguinal bypass surgery
  • International variation in treatment of peripheral arterial disease
  • Reducing groin wound complications

Vascular Surgery Clinical Trials

The Division of Vascular Surgery participates in a number of clinical trials. The vascular fellow will be aware of our clinical trials and receive education about how to engage in clinical trial research including the Institutional Review Board process.

Current Clinical Trials:

Multicenter, prospective, randomized clinical trial of a negative pressure incision management system in high risk vascular surgery patients: 5 center trial of the Prevena incisional wound VAC infrainguinal bypass with groin incision or femoral endarterectomy
Lead site, Principle investigator, Daniel Bertges, MD

Bard® LifeStent® Vascular Stent Systems
BPV-16-003: Popliteal Indication Post-Approval Surveillance Protocol: Vascular Quality Initiative Registry-based study for expanding indication of distal popliteal artery intervention with Bard Lifestent.
Chairman of Steering committee, Daniel Bertges, MD
Participating site, subsite investigator, Daniel Bertges, MD

IN.PACT Admiral DCB In-stent Restenosis (ISR) Post-market Registry: Vascular Quality Initiative Registry-based study for expanding indication of in-stent restenosis of the superficial-femoral popliteal artery with the IN.PACT Admiral Drug Coated Balloon.
Chairman of Steering committee, Daniel Bertges, MD
Participating site, subsite investigator, Matthew alef, MD

Completed Clinical Trials:
LEOPARD: Looking at EVAR Outcomes by Primary Analysis of Randomized Data: Multicenter, Observational, Post-Market, Real World Study to Assess Outcomes of Patients Treated with the AFX System compared to other EVAR devices for Endovascular Abdominal
Aortic Aneurysm Repair.
Participating site; subsite-principle investigator, Matthew Alef, MD